171 related articles for article (PubMed ID: 24164913)
1. FGF-23 and cognitive performance in hemodialysis patients.
Drew DA; Tighiouart H; Scott TM; Lou KV; Fan L; Shaffi K; Weiner DE; Sarnak MJ
Hemodial Int; 2014 Jan; 18(1):78-86. PubMed ID: 24164913
[TBL] [Abstract][Full Text] [Related]
2. Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients.
Unver S; Kavlak E; Gümüsel HK; Celikbilek F; Esertas K; Muftuoglu T; Kirilmaz A
Ren Fail; 2015 Jul; 37(6):951-6. PubMed ID: 26030798
[TBL] [Abstract][Full Text] [Related]
3. Low 25-hydroxyvitamin D levels and cognitive impairment in hemodialysis patients.
Shaffi K; Tighiouart H; Scott T; Lou K; Drew D; Weiner D; Sarnak M
Clin J Am Soc Nephrol; 2013 Jun; 8(6):979-86. PubMed ID: 23449769
[TBL] [Abstract][Full Text] [Related]
4. Cognitive function and all-cause mortality in maintenance hemodialysis patients.
Drew DA; Weiner DE; Tighiouart H; Scott T; Lou K; Kantor A; Fan L; Strom JA; Singh AK; Sarnak MJ
Am J Kidney Dis; 2015 Feb; 65(2):303-11. PubMed ID: 25240262
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis.
Seeherunvong W; Abitbol CL; Chandar J; Rusconi P; Zilleruelo GE; Freundlich M
Pediatr Nephrol; 2012 Nov; 27(11):2129-2136. PubMed ID: 22710695
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.
Gutiérrez OM; Januzzi JL; Isakova T; Laliberte K; Smith K; Collerone G; Sarwar A; Hoffmann U; Coglianese E; Christenson R; Wang TJ; deFilippi C; Wolf M
Circulation; 2009 May; 119(19):2545-52. PubMed ID: 19414634
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 23 and left ventricular mass index in maintenance hemodialysis patients: standard versus long nocturnal hemodialysis.
Knap B; Večerić-Haler Ž; Benedik M; Buturović-Ponikvar J; Ponikvar R; Bren AF
Ther Apher Dial; 2013 Aug; 17(4):407-11. PubMed ID: 23931880
[TBL] [Abstract][Full Text] [Related]
8. Association between fibroblast growth factor 23 and left ventricular hypertrophy in maintenance hemodialysis patients. Comparison with B-type natriuretic peptide and cardiac troponin T.
Negishi K; Kobayashi M; Ochiai I; Yamazaki Y; Hasegawa H; Yamashita T; Shimizu T; Kasama S; Kurabayashi M
Circ J; 2010 Nov; 74(12):2734-40. PubMed ID: 21041973
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.
Gutiérrez OM; Mannstadt M; Isakova T; Rauh-Hain JA; Tamez H; Shah A; Smith K; Lee H; Thadhani R; Jüppner H; Wolf M
N Engl J Med; 2008 Aug; 359(6):584-92. PubMed ID: 18687639
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.
Smith K; deFilippi C; Isakova T; Gutiérrez OM; Laliberte K; Seliger S; Kelley W; Duh SH; Hise M; Christenson R; Wolf M; Januzzi J
Am J Kidney Dis; 2013 Jan; 61(1):67-73. PubMed ID: 22883134
[TBL] [Abstract][Full Text] [Related]
11. Cognitive Decline and Its Risk Factors in Prevalent Hemodialysis Patients.
Drew DA; Weiner DE; Tighiouart H; Duncan S; Gupta A; Scott T; Sarnak MJ
Am J Kidney Dis; 2017 Jun; 69(6):780-787. PubMed ID: 28131531
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor is associated to left ventricular mass index, anemia and low values of transferrin saturation.
Eser B; Yayar O; Buyukbakkal M; Erdogan B; Ercan Z; Merhametsiz O; Haspulat A; Oğuz EG; Dogan İ; Canbakan B; Ayli MD
Nefrologia; 2015; 35(5):465-72. PubMed ID: 26394828
[TBL] [Abstract][Full Text] [Related]
13. Higher fibroblast growth factor-23 concentrations associate with left ventricular systolic dysfunction in dialysis patients.
Sharma S; Joseph J; Chonchol M; Kaufman JS; Cheung AK; Rafeq Z; Smits G; Kendrick J;
Clin Nephrol; 2013 Nov; 80(5):313-21. PubMed ID: 23849306
[TBL] [Abstract][Full Text] [Related]
14. The kidney disease quality of life cognitive function subscale and cognitive performance in maintenance hemodialysis patients.
Sorensen EP; Sarnak MJ; Tighiouart H; Scott T; Giang LM; Kirkpatrick B; Lou K; Weiner DE
Am J Kidney Dis; 2012 Sep; 60(3):417-26. PubMed ID: 22425261
[TBL] [Abstract][Full Text] [Related]
15. Frequency of and risk factors for poor cognitive performance in hemodialysis patients.
Sarnak MJ; Tighiouart H; Scott TM; Lou KV; Sorensen EP; Giang LM; Drew DA; Shaffi K; Strom JA; Singh AK; Weiner DE
Neurology; 2013 Jan; 80(5):471-80. PubMed ID: 23303848
[TBL] [Abstract][Full Text] [Related]
16. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephrol Dial Transplant; 2009 Sep; 24(9):2792-6. PubMed ID: 19395730
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and correlates of cognitive impairment in hemodialysis patients: the Frequent Hemodialysis Network trials.
Kurella Tamura M; Larive B; Unruh ML; Stokes JB; Nissenson A; Mehta RL; Chertow GM;
Clin J Am Soc Nephrol; 2010 Aug; 5(8):1429-38. PubMed ID: 20576825
[TBL] [Abstract][Full Text] [Related]
18. Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients.
Kirkpantur A; Balci M; Gurbuz OA; Afsar B; Canbakan B; Akdemir R; Ayli MD
Nephrol Dial Transplant; 2011 Apr; 26(4):1346-54. PubMed ID: 20813767
[TBL] [Abstract][Full Text] [Related]
19. FGF-23 is associated with cardiac troponin T and mortality in hemodialysis patients.
Holden RM; Beseau D; Booth SL; Adams MA; Garland JS; Morton RA; Collier CP; Foley RN
Hemodial Int; 2012 Jan; 16(1):53-8. PubMed ID: 22099949
[TBL] [Abstract][Full Text] [Related]
20. Correlates of left ventricular mass in chronic hemodialysis recipients.
Wald R; Goldstein MB; Wald RM; Harel Z; Kirpalani A; Perl J; Yuen DA; Wolf MS; Yan AT
Int J Cardiovasc Imaging; 2014 Feb; 30(2):349-56. PubMed ID: 24293047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
